Introduction: useful protection panel screening employs practical assays, kinase/transporter profiling, and Highly developed visualization to detect off-goal liabilities early, improving upon preclinical safety assessments. Just past week, a late-stage drug prospect unexpectedly confirmed adverse effects that hadn’t appeared in previously assays